REPRIEVE Study Addresses Burden of Heart Disease in HIV

The REPRIEVE study, a global study investigating the cardiovascular disease and AIDS, recently published primary results showing that pitavastatin calcium lowers the rate of heart disease for people living with HIV by 35%.  Dr. Gerald Bloomfield, a GHP graduate and the Associate Director for Research at DGHI, is a study cardiologist and serves on the risk panel for the project.

Read more about the findings, the study’s goals, and Dr. Bloomfield’s involvement here